SSWM
REGN icon

Strait & Sound Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Strait & Sound Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$445K Buy
714
+26
+4% +$17.7K 0.16% 103
2026
Q1 		$532K Buy
688
+14
+2% +$10.7K 0.2% 91
2025
Q4 		$520K Buy
674
+46
+7% +$31.2K 0.19% 90
2025
Q3 		$353K Buy
628
+21
+3% +$11.9K 0.14% 111
2025
Q2 		$319K Buy
+607
New +$339K 0.14% 116

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Strait & Sound Wealth Management's REGN Position: Q2 2026 in Review

Strait & Sound Wealth Management increased its Regeneron Pharmaceuticals (REGN) stake by 3.8% in Q2 2026, buying an estimated $17.7K and bringing the position to 714 shares worth $445K. The position accounts for 0.16% of the portfolio, ranked #103.

Strait & Sound Wealth Management first reported a position in REGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $532K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Strait & Sound Wealth Management held 714 shares of Regeneron Pharmaceuticals worth $445K as of Q2 2026.
  • Strait & Sound Wealth Management bought 26 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $17.7K.
  • Regeneron Pharmaceuticals made up 0.16% of Strait & Sound Wealth Management's portfolio in Q2 2026, its #103 holding.
  • Strait & Sound Wealth Management first reported a position in Regeneron Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Strait & Sound Wealth Management's Regeneron Pharmaceuticals position peaked at $532K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Strait & Sound Wealth Management's 13F filing for Q2 2026, filed 18 Aug 2026.